Cor Vasa 2009, 51(Suppl.):69-72 | DOI: 10.33678/cor.2009.226

Contrast-induced nephropathy

David Zemánek
Kardiologické oddělení Kardiovaskulárního centra, Fakultní nemocnice v Motole, Praha, Česká republika

Contrast-induced nephropathy is a relatively common complication associated with the use of iodinated contrast media during cardiac catheterization procedures. Although the increase in serum creatinine is transient in most cases, it is generally associated with increased morbidity and mortality rates, especially in the high-risk population. This review summarizes current findings regarding the pathophysiology and strategy for preventing and treating this complication.

Keywords: Contrast-induced nephropathy; Iodinated contrast media; Percutaneous catheterization intervention

Published: December 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zemánek D. Contrast-induced nephropathy. Cor Vasa. 2009;51(Suppl.):69-72. doi: 10.33678/cor.2009.226.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Liss P, Persson PB, Hansell P, Lagerqvist B. Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media. Kidney Int 2006;70:1811-7. Go to original source... Go to PubMed...
    2. Bartholomew BA, Harjai KJ, Dukkipati S, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 2004;93:1515-9. Go to original source... Go to PubMed...
    3. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996;275:1489-94. Go to original source...
    4. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importace of acute renal failure after percutaneous coronary intervention. Circulation 2002;105:2259-64. Go to original source... Go to PubMed...
    5. Lindsay J, Canos DA, Apple S, et al. Percutaneous coronary intervention-associated nephropathy foreshadows increased risk of late averse events in patient with normal baseline serum creatinine. Catheter Cardiovasc Interv 2003;59:338-43. Go to original source... Go to PubMed...
    6. Marenzi G, Lauri G, Assanelli E, et al. Contrast-induced nepropathy in patiens undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2004;44:1780-5. Go to original source... Go to PubMed...
    7. Caldicott WJH, Hollenberg NK, Abrams HL. Characteristics of response of renal vascular bed to contrast media. Evidence of vasoconstriction induced by renin-angiotensin system. Invest Radiol 1970;5:539-47. Go to original source... Go to PubMed...
    8. Russo D, Minutolo R, Cianciaruso B, et al. Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J Am Soc Nephrol 1995;6:1451-8. Go to original source... Go to PubMed...
    9. Moreau JF, Droz D, Noel LE, Leibowitch J, Jungers P, Michel JR. Tubular nephrotoxicity of water-soluble iodinated contrast media. Invest Radiol 1980;15:S54-S60. Go to original source... Go to PubMed...
    10. Hizoh I, Strater J, Schick CS, Kubler W, Haller C. Radiocontrast-induced DNA fragmentation of renal tubular cells in vitro: role of hypertonicity. Nephrol Dial Transplant 1998;13:911-8. Go to original source... Go to PubMed...
    11. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41. Go to original source... Go to PubMed...
    12. Laskey WK, Jenkins Ch, Selzer F, et al. Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. J Am Coll Cardiol 2007;50:584-90. Go to original source... Go to PubMed...
    13. Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial. The Iohexol Cooperative study. Kidney Int 1995;47:254-61. Go to original source... Go to PubMed...
    14. McCullough PA, Bertrand ME, Brinker JA, Stacul F. A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. J Am Coll Cardiol 2006;48:692-9. Go to original source... Go to PubMed...
    15. Mehran R, Aymong ED, Bukolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention. J Am Coll Cardiol 2004;44:1393-9. Go to original source... Go to PubMed...
    16. Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002;162:329-36. Go to original source... Go to PubMed...
    17. Tepel M, van der Giet M, Schwarzfeld C, et al. Prevention of radioraphic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000;343:180-4. Go to original source... Go to PubMed...
    18. Brar SS, Shen AY, Jorgensen MB, et al. Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial. JAMA 2008;300:1038-46. Go to original source... Go to PubMed...
    19. Stacul F, Adam A, Becker CR, et al. Strategies to reduce the risk of contrast-induced nephropathy. Am J Cardiol 2006;98:K59-K77. Go to original source... Go to PubMed...
    20. Tepel M, van der Giet M, Schwarzfeld C, et al. Prevention of radiographic-contrast-induced reduction in renal function by acetylcysteine. N Engl J Med 2000;343:180-4. Go to original source... Go to PubMed...
    21. Vaitkus PT, Brar C. N-acetylcysteine in the prevention of contrast-induced nephropathy: publication bias perpetuated by meta-analyses. Am Heart J 2007;153:275-80. Go to original source... Go to PubMed...
    22. Spargias K, Alexopoulos E, Kyrzopoulos S, et al. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 2004;110:2837-42. Go to original source... Go to PubMed...
    23. Khanal S, Attallah N, Smith DE, et al. Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions. Am J Med 2005;18:843-9. Go to original source... Go to PubMed...
    24. Stone GW, McCullough P, Tumlin J, et al. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA 2003;290:2284-91. Go to original source... Go to PubMed...
    25. Marenzi G, Marana I, Lauri G, et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 2003;349:1333-40. Go to original source... Go to PubMed...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes